Categories: Rare diseases, Neuronal diseases, Nephrological diseases, Bone diseases, Skin diseases, Muscle diseases
Aliases & Descriptions for Dermatomyositis:
Orphanet epidemiological data:51
Inheritance: Not applicable; Prevalence: 1-9/1000000 (Europe),1-9/100000 (Europe),1-9/1000000 (Australia),1-9/100000 (Australia),1-9/1000000 (Argentina),1-5/10000 (Argentina),1-9/1000000 (United States),1-9/1000000 (Spain); Age of onset: All ages; Age of death: any age
Global: Rare diseases
Anatomical: Neuronal diseases, Nephrological diseases, Bone diseases, Skin diseases, Muscle diseases
ICD10: 28 27
Rare neurological diseases
Rare renal diseases
Rare systemic and rhumatological diseases
Rare skin diseases
NIH Rare Diseases:45 Amyopathic dermatomyositis is a form of dermatomyositis characterized by the presence of typical skin findings without muscle weakness. some of the skin changes that suggest dermatomyositis include a pink rash on the face, neck, forearms and upper chest; gottron's papules and heliotrope eyelids. pruritis and photosensitivity are common, as is scalp inflammation and thinning of the hair. while patients with amyopathic dermatomyositis should not have clinically evident muscle weakness, minor muscle abnormalities may be included. fatigue is reported in at least 50% of patients. some cases have been associated with internal malignancy and/or interstitial lung disease. treatment may include sun avoidance, ample use of sunscreen, topical corticosteroids, antimalarial agents, methotrexate, mycophenolate mofetil, or intravenous (iv) immunoglobulin. last updated: 1/10/2013
MalaCards based summary: Dermatomyositis, also known as amyopathic dermatomyositis, is related to childhood type dermatomyositis and gingival overgrowth, and has symptoms including abnormality of the eye, muscle weakness and autoimmunity. An important gene associated with Dermatomyositis is IFIH1 (Interferon Induced With Helicase C Domain 1), and among its related pathways are Regulation of TP53 Activity through Acetylation and tRNA Aminoacylation. The drugs immunoglobulins, intravenous and potassium aminobenzoate have been mentioned in the context of this disorder. Affiliated tissues include muscle or, skin and lung, and related mouse phenotype mortality/aging.
Disease Ontology:10 A myositis that results in inflammation located in muscle or located in skin where a skin rash is often seen prior to the onset of muscle weakness. The disease may result from either a viral infection or an autoimmune reaction.
NINDS:46 Dermatomyositis is one of a group of muscle diseases known as the inflammatory myopathies, which are characterized by chronic muscle inflammation accompanied by muscle weakness.
Wikipedia:68 Dermatomyositis (DM) is a rare neuromuscular disease related to polymyositis (PM) that is characterized... more...
Symptoms:51 (show all 50)
HPO human phenotypes related to Dermatomyositis:(show all 43)
Drugs for Dermatomyositis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):(show top 50) (show all 91)
Interventional clinical trials:(show top 50) (show all 65)
Search NIH Clinical Center for Dermatomyositis
Inferred drug relations via UMLS65/NDF-RT43:
MalaCards organs/tissues related to Dermatomyositis:33
Skin, Lung, Heart, Breast, Bone, Liver, Prostate
FMA organs/tissues related to Dermatomyositis:16
Articles related to Dermatomyositis:(show top 50) (show all 1152)
Search GEO for disease gene expression data for Dermatomyositis.
Pathways related to Dermatomyositis according to GeneCards Suite gene sharing:
Biological processes related to Dermatomyositis according to GeneCards Suite gene sharing:
Molecular functions related to Dermatomyositis according to GeneCards Suite gene sharing:
28ICD10 via Orphanet
37MESH via Orphanet
50OMIM via Orphanet
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
66UMLS via Orphanet